Geovax Labs Inc is us-based clinical-stage biotechnology company. Geovax Labs Inc is us-based clinical-stage biotechnology company.
ATLANTA, Ga., Oct. 02, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced...
ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...
ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...
Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for Control, Treatment, and Prevention ATLANTA, GA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- GeoVax...
ATLANTA, GA, Aug. 20, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6 | -21.5053763441 | 2.79 | 2.79 | 2.02 | 527198 | 2.4293395 | CS |
4 | -2.15 | -49.5391705069 | 4.34 | 4.46 | 2.02 | 990363 | 3.09094368 | CS |
12 | -0.27 | -10.9756097561 | 2.46 | 11.18 | 1.6 | 4948893 | 6.07904448 | CS |
26 | 0.16 | 7.88177339901 | 2.03 | 11.18 | 1.0901 | 3703049 | 4.87830572 | CS |
52 | -5.64 | -72.030651341 | 7.83 | 11.18 | 1.0901 | 1963094 | 4.93046905 | CS |
156 | -60.51 | -96.5071770335 | 62.7 | 84.15 | 1.0901 | 3702864 | 27.03881948 | CS |
260 | -42.81 | -95.1333333333 | 45 | 130.65 | 1.0901 | 3179040 | 33.66986098 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.